Article info

Download PDFPDF

Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer

Authors

  1. Correspondence to Dr Megumi Ishiguro; ishiguro.srg2{at}tmd.ac.jp
View Full Text

Citation

Kusumoto T, Ishiguro M, Nakatani E, et al
Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer

Publication history

  • Received July 26, 2018
  • Revised August 14, 2018
  • Accepted August 15, 2018
  • First published October 7, 2018.
Online issue publication 
October 07, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.